Prof Saul Faust, co-study leader at the University of Southampton and a consultant paediatrician, said: “These latest results show that this long-acting antibody is safe and could protect thousands of babies from hospitalisation when used in conditions similar to routine clinical practice. It is really important information for the UK to help decide on options […]
The Centers for Disease Control and Prevention (CDC) is warning health providers that there is an “urgent need” to increase vaccinations against influenza, COVID-19 and respiratory syncytial virus (RSV). In an alert published Thursday, the agency cautioned that low vaccination rates, coupled with ongoing increases in national respiratory disease activity, could lead to more severe disease […]
The Biden administration on Monday met with the manufacturers of RSV immunizations to discuss making the medications available through the private market and preparing for next year as demand for the products far exceeded what drugmakers anticipated this season. A readout from the White House said on Tuesday that officials met with drugmakers to discuss […]
More than a third of Americans say they are worried that they or one of their family members will contract a seasonal respiratory virus like the flu, COVID-19 or RSV in the coming months, though vaccine enthusiasm appears to be middling at best. The survey was conducted by the Annenberg Public Policy Center of the […]
A group of Senate Democrats are demanding answers about a shortage of a new drug that prevents respiratory syncytial virus (RSV) in infants. In a letter led by Sen. Tammy Duckworth (D-Ill.) sent Friday, the lawmakers asked manufacturers AstraZeneca and Sanofi for more information about the current supply of nirsevimab, when the companies first became […]
The Centers for Disease Control and Prevention (CDC) said it was releasing 77,000 additional doses of a respiratory syncytial virus (RSV) drug from Sanofi and AstraZeneca to help improve its availability. The additional doses of Beyfortus will be distributed immediately to physicians and hospitals through the Vaccines for Children Program, which covers the cost of […]
A supply shortage means a drug that can prevent respiratory syncytial virus (RSV) in infants won’t have a major immediate impact, children’s hospitals said, and they are preparing for a surge in admissions this respiratory disease season. “Widespread access [to the new antibody drug] will take time across many sectors of the pediatric population and […]
Insurance barriers and distribution challenges are marring the rollout of highly anticipated new shots to protect babies from respiratory syncytial virus (RSV) and young kids from COVID-19, drawing anger and frustration from parents and pediatricians. Medical practices don’t know when, or how much, they will get paid for the pricey RSV shot, and they are […]
The advisory committee on immunizations for the Centers for DIsease Control and Prevention (CDC) voted to recommend an RSV vaccine designed to give newborn infants protection against the virus before they’re born. The CDC’s Advisory Committee on Immunization Practices (ACIP) voted 11-1 in favor of approving Pfizer’s Abrysvo for use in pregnant women during weeks […]
The Food and Drug Administration (FDA) on Monday approved the first vaccine meant to prevent infections in infants, with the new drug designed to be administered to pregnant mothers in their third trimester so their newborn infants can have protection from the moment they’re born. The single-dose injections called Abrysvo is made by Pfizer and […]